Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
1.385 / 17.032
#11073

Re: Farmas USA

THRESHOLD PHARMACEUTICALS (NASDAQ:THLD) Weak Uptrend
Smart Scan Chart Analysis shows that positive longer term is weakening. The market action could signal the start of a major trend change Weak Uptrend Very tight money management stops.
Based on a pre-defined weighted trend formula for chart analysis, THLD scored +65 on a scale from -100 (strong downtrend) to +100 (strong uptrend):


+10 Last Hour Close Above 5 Hour Moving Average
-15 New 3 Day Low on Thursday
-20 Last Price Below 20 Day Moving Average
+25 New 3 Week High, May 30th
+30 New 3 Month High on February 3

+65 Total Score


Open High Low THLD Price Change
7.120 7.270 6.910 7.175 +0.035


ARENA PHARMACEUTICALS (NASDAQ:ARNA) Sidelines Mode
Smart Scan Chart Analysis indicates a counter trend rally is underway The current up-trend could be changing and moving into a trading range Sidelines Mode.
Based on a pre-defined weighted trend formula for chart analysis, ARNA scored +55 on a scale from -100 (strong downtrend) to +100 (strong uptrend):


-10 Last Hour Close Below 5 hour Moving Average
-15 New 3 Day Low on Wednesday
-20 Last Price Below 20 Day Moving Average
+25 New 3 Week High, May 8th
+30 New 3 Month High on December 2

+55 Total Score


Open High Low ARNA Price Change
9.770 9.850 9.370 9.515 -0.135


NAVIDEA (AMEX:NAVB) Strong Uptrend
Smart Scan Chart Analysis confirms that a strong uptrend is in place and that the market remains positive longer term. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.
Based on a pre-defined weighted trend formula for chart analysis, NAVB scored +100 on a scale from -100 (strong downtrend) to +100 (strong uptrend):


+10 Last Hour Close Above 5 Hour Moving Average
+15 New 3 Day High on Wednesday
+20 Last Price Above 20 Day Moving Average
+25 New 3 Week High, June 13th
+30 New 3 Month High on January 30

+100 Total Score


Open High Low NAVB Price Change
4.59 4.67 4.51 4.65 +0.11


ACHILLION PHARMACEUTICALS (NASDAQ:ACHN) Downtrend
Smart Scan Chart Analysis is showing some near term rallying power. However, this market remains in the confines of a longer-term Downtrend with tight money management stops.
Based on a pre-defined weighted trend formula for chart analysis, ACHN scored -75 on a scale from -100 (strong downtrend) to +100 (strong uptrend):


-10 Last Hour Close Below 5 hour Moving Average
-15 New 3 Day Low on Friday
-20 Last Price Below 20 Day Moving Average
+25 New 3 Week High, July 5th
-30 New 3 Month Low on April 19

-75 Total Score


Open High Low ACHN Price Change
6.59 6.68 6.34 6.37 -0.28


HORIZON PHARMA (NASDAQ:HZNP) Uptrend
Smart Scan Chart Analysis is showing some near term weakness. However, this market remains in the confines of a longer term Uptrend with tight money management stops.
Based on a pre-defined weighted trend formula for chart analysis, HZNP scored +75 on a scale from -100 (strong downtrend) to +100 (strong uptrend):


-10 Last Hour Close Below 5 hour Moving Average
-15 New 3 Day Low on Wednesday
+20 Last Price Above 20 Day Moving Average
+25 New 3 Week High, June 12th
+30 New 3 Month High on June 13

+75 Total Score


Open High Low HZNP Price Change
7.1200 7.3900 7.0700 7.2001 +0.0801


AMARIN (NASDAQ:AMRN) Strong Uptrend
Smart Scan Chart Analysis confirms that a strong uptrend is in place and that the market remains positive longer term. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.
Based on a pre-defined weighted trend formula for chart analysis, AMRN scored +100 on a scale from -100 (strong downtrend) to +100 (strong uptrend):


+10 Last Hour Close Above 5 Hour Moving Average
+15 New 3 Day High on Monday
+20 Last Price Above 20 Day Moving Average
+25 New 3 Week High, April 26th
+30 New 3 Month High on February 6

+100 Total Score


Open High Low AMRN Price Change
15.18 15.27 14.85 15.13 -0.23


ZALICUS (NASDAQ:ZLCS) Very Weak Downtrend
Smart Scan Chart Analysis shows the current downward trend is at a crossroads and has possibly ended. Look for choppy trading action in the nearterm Very Weak Downtrend with very tight stops.
Based on a pre-defined weighted trend formula for chart analysis, ZLCS scored -60 on a scale from -100 (strong downtrend) to +100 (strong uptrend):


+10 Last Hour Close Above 5 Hour Moving Average
-15 New 3 Day Low on Friday
-20 Last Price Below 20 Day Moving Average
-25 New 3 Week Low, July 16th
+30 New 3 Month High on June 11

-60 Total Score


Open High Low ZLCS Price Change
1.05 1.06 1.02 1.02 -0.03

#11074

Re: Farmas USA

Merece entrar en el link aunque sea por la tia que esta de rechupete :D

#11075

Re: Farmas USA

Buenos días,

llevó bastante tiempo siguiendo este hilo, pero hasta hoy no me he atrevido a postear nada, pues llevo muy poquito tiempo en este mundillo y mis conocimientos son todavía bastante limitados. Estoy en algunas de las farmas que posteais por aquí (las famosas ARNA y THLD, ZLCS...). Ante todo quería agradeceros a todos vuestra labor desinteresada que a los más inexpertos nos está sirviendo para ir aprendiendo y adentrándonos en este complejo mundo de la bolsa.
Hace unos cuantos días Pedro AT (creo que fue el), menciono CTIC (Cell Therapeutics), ¿como la véis en el corto medio plazo?
De nuevo Muchas gracias¡¡¡...y a ver si poco a poco puedo ir aportando alguna cosilla...

#11076

Re: Farmas USA

Yo tenía pensado entrar el viernes (que lo hice) y vender el lunes o el martes, cuando subiera algo, antes del bear ride. El tema es ¿a qué precio vendo? ¿habrá bear ride? ¿adelantarán la aprobación? hoy lo consulté con la almohada pero no me dio respuesta, jeje.

#11078

Re: Farmas USA

Excelente artículo y muy clarificador.

Saludos

#11079

Re: Farmas USA

Hasta donde yo entiendo (y google traduce, jejejeje), esto es un concurso de 10$ (bastante jugoso) en el que va a participar Life Technologies Corp, y Gnom hasta que no sepa como se va a medir los resultados no dira si se presena o no.
Remarca que Illumina ha decidido no entrar, jejeje

No se... como veis la noticia? Es mas o menos lo que he resumido?

Te puede interesar...
  1. Inflación y tipos en el punto de mira, la historia no se repite pero rima
  2. La Euforia Post-Trump: ¿Calma o Tormenta en el Mercado?